BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15163016)

  • 1. Microvascular density does not correlate with histopathology and outcome in neuroendocrine tumors of the pancreas.
    Tan G; Cioc AM; Perez-Montiel D; Ellison EC; Frankel WL
    Appl Immunohistochem Mol Morphol; 2004 Mar; 12(1):31-5. PubMed ID: 15163016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of gremlin 1 correlates with increased angiogenesis and progression-free survival in patients with pancreatic neuroendocrine tumors.
    Chen MH; Yeh YC; Shyr YM; Jan YH; Chao Y; Li CP; Wang SE; Tzeng CH; Chang PM; Liu CY; Chen MH; Hsiao M; Huang CY
    J Gastroenterol; 2013 Jan; 48(1):101-8. PubMed ID: 22706573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenon-inhalation computed tomography for noninvasive quantitative measurement of tissue blood flow in pancreatic tumor.
    Kubota M; Murakami T; Nagano H; Eguchi H; Marubashi S; Kobayashi S; Wada H; Tanemura M; Dono K; Nakamori S; Sakon M; Monden M; Mori M; Doki Y
    Dig Dis Sci; 2012 Mar; 57(3):801-5. PubMed ID: 21953140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of tumor architecture, tumor-associated vascular characteristics, and expression of angiogenic molecules in pancreatic endocrine tumors.
    Takahashi Y; Akishima-Fukasawa Y; Kobayashi N; Sano T; Kosuge T; Nimura Y; Kanai Y; Hiraoka N
    Clin Cancer Res; 2007 Jan; 13(1):187-96. PubMed ID: 17200354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The distinctive characteristics of the micro-vasculature and immune cell infiltration in cystic pancreatic neuroendocrine tumors.
    Gao H; Wang W; Zhang W; Xu H; Wu C; Li H; Ni Q; Yu X; Liu L
    J Endocrinol Invest; 2021 May; 44(5):1011-1019. PubMed ID: 32856225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinicopathological significance of angiogenesis in hindgut neuroendocrine tumors obtained via an endoscopic procedure.
    Okubo Y; Motohashi O; Nakayama N; Nishimura K; Kasajima R; Miyagi Y; Shiozawa M; Yoshioka E; Suzuki M; Washimi K; Kawachi K; Nito M; Kameda Y; Yokose T
    Diagn Pathol; 2016 Nov; 11(1):128. PubMed ID: 27821179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis.
    Georgiadou D; Sergentanis TN; Sakellariou S; Filippakis GM; Zagouri F; Vlachodimitropoulos D; Psaltopoulou T; Lazaris AC; Patsouris E; Zografos GC
    Eur J Surg Oncol; 2014 Oct; 40(10):1331-7. PubMed ID: 24480377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphometric microvascular characteristics in the prognosis of pancreatic and ampullary carcinoma.
    Giannopoulos G; Kavantzas N; Parasi A; Tiniakos D; Peros G; Tzanakis N; Patsouris E; Pavlakis K
    Pancreas; 2007 Jul; 35(1):47-52. PubMed ID: 17575545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors.
    d'Assignies G; Couvelard A; Bahrami S; Vullierme MP; Hammel P; Hentic O; Sauvanet A; Bedossa P; Ruszniewski P; Vilgrain V
    Radiology; 2009 Feb; 250(2):407-16. PubMed ID: 19095784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors.
    Marion-Audibert AM; Barel C; Gouysse G; Dumortier J; Pilleul F; Pourreyron C; Hervieu V; Poncet G; Lombard-Bohas C; Chayvialle JA; Partensky C; Scoazec JY
    Gastroenterology; 2003 Oct; 125(4):1094-104. PubMed ID: 14517793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection.
    Niedergethmann M; Hildenbrand R; Wolf G; Verbeke CS; Richter A; Post S
    Int J Pancreatol; 2000 Aug; 28(1):31-9. PubMed ID: 11185708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nonfunctional neuroendocrine tumor of the pancreas - a case report.
    Mogoantă SŞ; Costache A; Muţiu G; Bungău SG; Ghiluşi M; Grosu F; Vasile M; Vîlcea ID; Gherghinescu MC; Mogoantă L; Ion DA
    Rom J Morphol Embryol; 2015; 56(2):511-9. PubMed ID: 26193221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of color Doppler vascularity index and microvessel density with survival in patients with gastric cancer.
    Chen CN; Cheng YM; Lin MT; Hsieh FJ; Lee PH; Chang KJ
    Ann Surg; 2002 Apr; 235(4):512-8. PubMed ID: 11923607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma.
    Seo Y; Baba H; Fukuda T; Takashima M; Sugimachi K
    Cancer; 2000 May; 88(10):2239-45. PubMed ID: 10820344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumors.
    Jang KM; Kim SH; Lee SJ; Choi D
    Acta Radiol; 2014 Mar; 55(2):140-8. PubMed ID: 23897307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological features and multivariate analysis of prognostic factors for patients with gastroenteropancreatic neuroendocrine tumors].
    Wang X; Song ZF; Yao WX; Pan CC; Xiang MF; Wang H
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1411-4. PubMed ID: 24025507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors.
    Del Prete M; Di Sarno A; Modica R; Lassandro F; Giorgio A; Bianco A; Muto M; Gasperi M; Del Prete F; Colao A; Montesarchio V; Faggiano A;
    J Endocrinol Invest; 2017 Dec; 40(12):1373-1380. PubMed ID: 28667452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Histological Vessel Characteristics and Diffusion-Weighted Imaging Intravoxel Incoherent Motion-Derived Parameters in Pancreatic Ductal Adenocarcinomas and Pancreatic Neuroendocrine Tumors.
    Klau M; Mayer P; Bergmann F; Maier-Hein K; Hase J; Hackert T; Kauczor HU; Grenacher L; Stieltjes B
    Invest Radiol; 2015 Nov; 50(11):792-7. PubMed ID: 26186280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathologic characteristics of 127 cases of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) studied in an oncology hospital].
    Alvarado-Cabrero I; de Anda-González J; Hernández-Hernández B; Mantilla-Morales A; Valencia-Cedillo R; Medrano-Guzmán R
    Rev Gastroenterol Mex; 2012; 77(4):174-80. PubMed ID: 23142406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.